Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.2428
Delayed Data
As of Jul 27
 -0.0072 / -2.88%
Today’s Change
0.06
Today|||52-Week Range
0.51
+115.82%
Year-to-Date
An Investing Overview of the Multiple Sclerosis Market
Jul 26 / MotleyFool.com - Paid Partner Content
Actelion (ALIOF) Beats Q2 Earnings & Revenues, View Up
Jul 22 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
Jul 25 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Benzinga's M&A Chatter for Thursday July 21, 2016:
Jul 21 / Benzinga - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Jul 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close0.25
Today’s open0.23
Day’s range0.23 - 0.25
Volume4,886
Average volume (3 months)433,790
Market cap--
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers

Search for Jobs